UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Nitrogen-containing bisphosphonates are associated with reduced risk of pneumonia in patients with hip fracture

Sing, CW; Kiel, DP; Hubbard, RB; Lau, WCY; Li, GHY; Kung, AWC; Wong, I; (2020) Nitrogen-containing bisphosphonates are associated with reduced risk of pneumonia in patients with hip fracture. Journal of Bone and Mineral Research , 35 (9) pp. 1676-1684. 10.1002/jbmr.4030. Green open access

[thumbnail of Article]
Preview
Text (Article)
Wong_NBPs_Pneu_JBMR_accepted.pdf - Accepted Version

Download (773kB) | Preview
[thumbnail of Online data supplement]
Preview
Text (Online data supplement)
Wong_NBPs_Pneu_JBMR_accepted_suppl.pdf - Accepted Version

Download (592kB) | Preview

Abstract

The objective of this work was to study the risk of pneumonia and pneumonia mortality among patients receiving nitrogen‐containing bisphosphonates (N‐BPs), non‐N‐BP anti‐osteoporosis medications, and no anti‐osteoporosis medications after hip fracture. We studied a historical cohort using a population‐wide database. Patients with first hip fracture during 2005–2015 were identified and matched by time‐dependent propensity score. The cohort was followed until December 31, 2016, to capture any pneumonia and pneumonia mortality. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox‐proportional hazards regression. Absolute risk difference (ARD) and number needed to treat (NNT) were calculated. We identified 54,047 patients with hip fracture. Of these, 4041 patients who received N‐BPs and 11,802 without anti‐osteoporosis medication were propensity score–matched. N‐BPs were associated with a significantly lower risk of pneumonia compared with no treatment (6.9 versus 9.0 per 100 person‐years; HR 0.76; 95% CI, 0.70 to 0.83), resulting in an ARD of 0.02 and NNT of 46. A similar association was observed with pneumonia mortality (HR 0.65; 95% CI, 0.56 to 0.75). When N‐BPs were compared with non‐N‐BP anti‐osteoporosis medications, the association remained significant. N‐BPs were associated with lower risks of pneumonia and pneumonia mortality. Randomized controlled trials are now required to determine whether N‐BPs, non–vaccine‐based medications, can reduce pneumonia incidence in high risk groups.

Type: Article
Title: Nitrogen-containing bisphosphonates are associated with reduced risk of pneumonia in patients with hip fracture
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/jbmr.4030
Publisher version: https://doi.org/10.1002/jbmr.4030
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy
URI: https://discovery.ucl.ac.uk/id/eprint/10094408
Downloads since deposit
Loading...
245Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item